Adamas Pharma (ADMS) Misses Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts ADMS Hot Sheet
Join SI Premium – FREE
Adamas Pharma (NASDAQ: ADMS) reported Q3 EPS of ($1.04), $0.06 worse than the analyst estimate of ($0.98).
For earnings history and earnings-related data on Adamas Pharma (ADMS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- BWS Financial Downgrades Inter Parfums (IPAR) to Sell
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
